//
//
COS for post-COVID-19 condition published in The Lancet Respiratory Medicine – access to study materials

COS for post-COVID-19 condition published in The Lancet Respiratory Medicine – access to study materials

17 June 2022
comfa-news

We are happy to announce a recent publication authored by Dr Daniel Munblit and Dr Nina Seylanova outlining the core outcome set for post-COVID-19 condition (PC-COS) in the Lancet Respiratory Medicine that embodies a stellar example of international project coordination that we aim to uphold within our Action.

The paper also contains a short podcast discussing the importance of COS for the post-COVID-19 condition. This information is relevant to everyone involved in any COS development project, so we hope you will find it useful!

Latest News

comfa-news
Title
"C3 Meeting" time change 
25 October 2022

Preview

We would still like to hold a meeting with those of you able to join and discuss the current itteration of the list of outcomes on the 4th of November during C3 meeting as some of us will be joining C3 anyway. The meeting will take place between 18.00 and 19.15 (UK time) on the 4th of November.
comfa-news
Title
The refined long list of outcomes
21 October 2022

Preview

We would like to thank everyone who have provided their feedback to the list of outcomes we circulated a week ago! Very grateful for your kind involvement, for finding time to comment. We would like to remind you that if you have not submitted your reimbursement for the Porto meeting please do not forget to claim it via 'e-cost'.
maxresdefault
Title
Important guidance
14 October 2022

Preview

Some important tips related to COS development. The concept is very straightforward, however, certain aspects may be unclear, somehow confusing and you may find information below useful. (a) It is very important to distinguish between “what to measure?” and “how to measure?”: The first step in the COS development is to undertake a Delphi on...